JCS Analytics
JCS Analytics
  • Home
  • About
  • Privacy

JCS Analytics - We are analysts. We Ask. We Automate. We Discover.

Details
By J. Smith
J. Smith
Articles
July 2,2026
Last Updated: 02 July 2026
Hits: 38
  • Responsible AI
  • AI Governance
  • FDA
  • AI Accountability
  • Human Review

When AI Isn’t Enough: What the FDA’s Purolea Warning Letter Teaches About AI Governance

The Accountability Gap

Summary

The FDA’s Purolea Cosmetics warning letter shows why AI governance matters. The issue wasn’t that Purolea used AI to help create compliance documents. The problem was that the company relied on AI-generated output without adequate qualified human review. The FDA and EMA’s good AI practice principles point to a better approach: define the context of use, assess risk, document decisions, involve the right expertise, and maintain accountability throughout the AI lifecycle. The broader lesson is clear: AI can assist with work, but the person or organization using it remains responsible.

Key Points

  • AI output doesn’t replace human accountability.
    The person or organization using AI still owns the accuracy, completeness, compliance, and appropriateness of the final work.
  • The FDA did not object to AI-assisted document creation itself.
    It objected to using AI-generated compliance documents without adequate qualified human review.
  • Good AI practice is a governance issue, not just a model performance issue.
    Context of use, validation, documentation, oversight, monitoring, and lifecycle management all matter.
  • The Purolea case has lessons beyond drug manufacturing.
    Similar risks can appear in analytics, reporting, compliance, audit preparation, and operational decision support.
  • AI can support judgment, but it can’t replace it.
    Speed, polish, and confidence are not the same as accuracy or accountability.

Read more: When AI Isn’t Enough: What the FDA’s Purolea Warning Letter Teaches About AI Governance

Details
By J. Smith
J. Smith
Articles
June 24,2026
Last Updated: 24 June 2026
Hits: 94
  • Tableau
  • Data Visualization
  • CGM Data
  • Visualization Design
  • Data Interpretation

Designing Visualizations That Help People Understand the Data

A Tableau Case Study Using Continuous Glucose Monitor Data

Time in Range by Hour

Thoughtful visualization design turns CGM data into clearer insight by showing when patterns occur, how stable they are, and how design choices influence the way people interpret the data.

Summary

Thoughtful data design makes complex patterns easier to understand. Hourly Time in Range and Variation by Hour views can reveal glucose patterns that daily summaries often hide, while choices around aggregation, paired metrics, color, and audience context shape whether data feels like judgment or useful information.

Key Points

  • Daily summaries can hide important timing patterns.
    A single Time in Range percentage may be useful, but it doesn’t show when glucose patterns occur.
  • Hourly aggregation provides better context.
    Grouping CGM readings by hour helps reveal recurring patterns across 7, 14, 30, or 90 days.
  • Time in Range and Variation work better together.
    Time in Range shows how often readings stay within range, while Variation by Hour shows how stable those readings are.
  • Visualization design choices affect interpretation.
    Color scales, labels, aggregation, and chart structure influence whether viewers see pattern, noise, pressure, or context.
  • Good analytics requires audience awareness.
    A chart should not only be accurate. It should fit the audience, the purpose, and the way the information may land.

Read more: Designing Visualizations That Help People Understand the Data

Details
By J. Smith
J. Smith
Articles
May 29,2026
Last Updated: 30 May 2026
Hits: 153
  • Data Analyst
  • Clinical Context
  • Healthcare Data Analysis
  • Domain Fluency
  • Medical Courses

Why I Take Medical Courses as a Data Analyst

From Skill to Insight

Summary

Cross-disciplinary learning across data analysis, AI, healthcare, medical research, and clinical context helps turn technical skill into more useful insight. The focus is domain fluency, not clinical authority: understanding what healthcare data means, why it matters, and how to communicate it clearly.

Key Points

  • Technical skill alone isn’t enough for healthcare data work.
    Analysts also need to understand the clinical, scientific, operational, and ethical context behind the data.
  • Medical and healthcare-focused courses build domain fluency.
    They help explain why certain measures, outcomes, patterns, and risks matter in real-world decision-making.
  • Data, AI, SQL, visualization, and statistics provide the technical foundation.
    These skills support efficient workflows, stronger analysis, and clearer communication of insight.
  • Clinical reasoning strengthens analytical judgment.
    Pattern recognition, ambiguity, hypothesis testing, and decision-making under uncertainty all translate well to data work.
  • Cross-disciplinary learning makes analysis more useful.
    Better healthcare analysis connects technical skill with context, communication, and the people represented by the data.

Read more: Why I Take Medical Courses as a Data Analyst

Details
By J. Smith
J. Smith
Articles
May 12,2026
Last Updated: 17 May 2026
Hits: 266
  • Responsible AI
  • AI Strategy
  • AI Infrastructure
  • Sovereign AI
  • Data Governance

Sovereign AI Infrastructure and the New Shape of AI Strategy

Evan Solomon, minister of artificial intelligence and digital innovation, speaks at a press event on Monday. Courtesy of The Canadian Press.

Summary

AI strategy increasingly depends on more than models, applications, prompts, and productivity tools. Canada’s recent work with TELUS on sovereign AI infrastructure offers a useful example of how compute capacity, data residency, jurisdiction, energy use, cooling systems, and governance are becoming part of the AI readiness conversation. For data analytics professionals, the announcement highlights a broader shift: responsible AI adoption requires strong data foundations, reliable infrastructure, clear governance, and careful attention to sustainability and public accountability.

Key Points

  • Large-scale AI depends on physical and digital infrastructure, including compute capacity, networks, energy, cooling systems, and data governance.
  • Sovereign AI infrastructure can help organizations keep data, intellectual property, and sensitive workloads under domestic legal and regulatory frameworks.
  • AI readiness requires more than access to a model. Organizations also need reliable data pipelines, secure environments, and production-ready infrastructure.
  • Compute capacity is becoming a strategic issue because it affects who can participate in advanced AI development, including businesses, researchers, startups, and public institutions.

Read more: Sovereign AI Infrastructure and the New Shape of AI Strategy

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9

Page 1 of 9

Recent Activity

July 2026

  • When AI Isn’t Enough: What the FDA’s Purolea Warning Letter Teaches About AI Governance

June 2026

  • Designing Visualizations That Help People Understand the Data
  • Novo Nordisk IT Incident Shows Why Pseudonymized Data Still Requires Serious Protection

May 2026

  • Lundbeck’s AI Days Show How Companies Can Make AI Adoption Practical
  • Sovereign AI Infrastructure and the New Shape of AI Strategy
  • Why I Take Medical Courses as a Data Analyst

April 2026

  • Novo Nordisk Expands Its AI Strategy Through New OpenAI Partnership

Articles

  • 5K@EASD Race Results: Trends from 2023 and 2024
  • Adapting the 5K@ADA Race Results Project for 2025
  • Advanced Data Retrieval with Python
  • Aligning CGM and BGM Readings Using Python and Tableau
  • Analysis and Visualization of Public Health Agency of Canada COVID Cases
  • Bridging Data and Healthcare in the Nordics
  • Complex Web Scraping with Python
  • Creating a Calculated Field in Tableau to Get Get Data Aggregated by Month in the Correct Order
  • Data Analyst vs. Business Analyst: Similarities and Differences
  • Data Analytics for Type 2 Diabetes
  • Data Science and Responsible AI in the Pharmaceutical Industry: A Case Study of Novo Nordisk
  • Denmark's Leap into AI Innovation: A Model for Future Research and Development
  • Denmark’s Gefion AI Supercomputer Revolutionizes AI-driven Research
  • Designing Visualizations That Help People Understand the Data
  • Eli Lilly’s AI Strategy: Opening High-Value Drug Discovery Models to the Biotech Ecosystem
  • Embracing AI: Balancing Augmentation, Ethics, and Environmental Impact
  • Enhancing Data Analysis and Visualization Workflows with AI
  • Exploring the 2023 5K@EASD Virtual Run: A Tableau Analysis
  • Exploring the Growth of GLP-1 RA Sales
  • How Novo Nordisk is Utilizing AI for Drug Discovery

Top Subjects

  • Tableau
  • Python
  • Data Analytics
  • Novo Nordisk
  • Data Visualization
  • Tableau Visualizations
  • AI
  • 5K@EASD
  • Data Analysis
  • 5K@ADA
  • Responsible AI
  • AI Governance
  • Type 2 Diabetes
  • Data Cleaning
  • Data Analyst
  • Drug Discovery
  • AI Innovation
  • Quantum Computing
  • Diabetes Management
  • Race Results
  • Diabetes Awareness
  • Virtual 5K
  • SQLite
  • SQLite Database Management
  • Continuous Glucose Monitoring
  • Artificial Intelligence
  • AI in Healthcare
  • CGM Data
  • Healthcare Analytics
  • Healthcare Data

Contact Me

Search

End Diabetes Stigma

5K@ADA

5K@EASD

World Diabetes Day

Bluesky Social

  • You are here:  
  • Home
  • Articles
 
Copyright © 2026 JCS Analytics. All Rights Reserved.
Joomla! is Free Software released under the GNU General Public License.